HealthControversial US-backed vaccine trial in African newborns halted

The lead researcher said the hepatitis B vaccine trial planned in Guinea-Bissau, with funding from the US Centers for Disease Control and Prevention, will not proceed because the team did not receive the necessary government approval. The proposed study had drawn global backlash.

Guinea-Bissauhepatitis B vaccinenewbornsclinical trial

TThe Guardian★★★☆☆2026-10-21 17:18Original